6-chloro-3-(hydroxyimino)-2,3-dihydro-1H-indol-2-one, 97%, 1g

2-(3-Chlorophenyl)sulfanylacetonitrile, 95.0%, 250mg

2-Bromo-5-methylthiazole-4-carboxylic acid, 95.0%, 5g

3-FLUORO-3-(TRIFLUOROMETHYL)AZETIDINE HYDROCHLORIDE, 95%, 5g

Butanedioic acid, compd. with 7-cyclopentyl-N,N-dimethyl-2-[[5-(1-piperazinyl)-2-pyridinyl]amino]-7H-pyrrolo[2,3-d]pyrimidine-6-carboxamide (1:1), 98%, 250mg

4-Methyl-2-(piperidin-1-yl)quinoline, 98%, 25mg

2-Amino-3,5-dichloro-6-methylpyridine>97.0%(T)5g

Methyl (E)-2-[3-[3-[2-(7-chloro-2-quinolinyl)ethenyl]phenyl]-3-oxopropyl]benzoate, 97% mix TBC as stabilizer, 50mg

tert-butyl 2-methyl-3-(methylamino)propanoate, 95.0%, 2g

5-Methoxyindoline hydrochloride, 95.0%, 25g

Chromone-3-carboxaldehyde, 97.0%, 10g

tert-Butyl (1-(3-(hydroxymethyl)phenyl)ethyl)carbamate, 95.0%, 250mg

2,2-Dimethyl-N-[(1S)-2,2,2-trifluoro-1-(1-methyl-1H-indol-3-yl)ethyl]propanamide, 250mg